BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
-1.88%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$3.73B
AUM Growth
-$641M
(-15%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-11.84%
Top 10 Holdings %
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84
Top Buys
| 1 |
Automatic Data Processing
ADP
|
$11.6M |
| 2 |
Meta Platforms (Facebook)
META
|
$11.6M |
| 3 |
Tapestry
TPR
|
$11.4M |
| 4 |
Cleveland-Cliffs
CLF
|
$11M |
| 5 |
Ford
F
|
$8.8M |
Top Sells
| 1 |
L3Harris
LHX
|
$18.8M |
| 2 |
Cigna
CI
|
$14.8M |
| 3 |
Cummins
CMI
|
$14.7M |
| 4 |
Ameriprise Financial
AMP
|
$13.2M |
| 5 |
Waters Corp
WAT
|
$13.1M |
Sector Composition
| 1 | Financials | 27.37% |
| 2 | Energy | 11.69% |
| 3 | Industrials | 10.49% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Technology | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Minerva Neurosciences
NERV
$15.2M
| $149K | ﹤0.01% |
16,148
| – | – |
|
1202
Ocean Power Technologies
OPTT
$90.1M
| $148K | ﹤0.01% |
+180,000
| New | +$148K |
|
1203
Cabaletta Bio
CABA
$154M
| $147K | ﹤0.01% |
225,951
-28,601
| -11% | -$18.6K |
|
|
VAXX
1204
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $147K | ﹤0.01% |
+74,400
| New | +$147K |
|
1205
Quince Therapeutics
QNCX
$84.3M
| $146K | ﹤0.01% |
+110,000
| New | +$146K |
|
|
SONX
1206
DELISTED
Sonendo, Inc.
SONX
| $146K | ﹤0.01% |
136,500
-20,000
| -13% | -$21.4K |
|
1207
National CineMedia
NCMI
$435M
| $145K | ﹤0.01% |
22,200
+2,200
| +11% | +$14.4K |
|
1208
Travelzoo
TZOO
$108M
| $145K | ﹤0.01% |
32,643
-20,000
| -38% | -$88.8K |
|
|
IVC
1209
DELISTED
Invacare Corporation
IVC
| $145K | ﹤0.01% |
185,496
-10,000
| -5% | -$7.82K |
|
1210
Aware
AWRE
$58.4M
| $144K | ﹤0.01% |
80,679
| – | – |
|
1211
Hyperfine
HYPR
$93.5M
| $142K | ﹤0.01% |
175,000
+25,000
| +17% | +$20.3K |
|
1212
Key Tronic
KTCC
$34.5M
| $141K | ﹤0.01% |
34,800
| – | – |
|
1213
Westwater Resources
WWR
$61.8M
| $141K | ﹤0.01% |
123,700
| – | – |
|
1214
Splash Beverage Group
SBEV
$3.41M
| $140K | ﹤0.01% |
2,558
-1,125
| -31% | -$61.6K |
|
1215
Protalix BioTherapeutics
PLX
$126M
| $139K | ﹤0.01% |
133,790
-25,000
| -16% | -$26K |
|
1216
ThredUp
TDUP
$1.37B
| $138K | ﹤0.01% |
+75,000
| New | +$138K |
|
1217
Solid Biosciences
SLDB
$399M
| $138K | ﹤0.01% |
19,687
| – | – |
|
1218
Backblaze
BLZE
$516M
| $137K | ﹤0.01% |
27,500
| – | – |
|
1219
Stereotaxis
STXS
$262M
| $137K | ﹤0.01% |
+76,200
| New | +$137K |
|
|
PVLA
1220
Palvella Therapeutics, Inc. Common Stock
PVLA
$609M
| $134K | ﹤0.01% |
1,456
-1,208
| -45% | -$111K |
|
1221
Dyne Therapeutics
DYN
$1.89B
| $132K | ﹤0.01% |
10,400
-6,000
| -37% | -$76.2K |
|
|
LHDX
1222
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $132K | ﹤0.01% |
124,700
+37,000
| +42% | +$39.2K |
|
|
DS
1223
DELISTED
Drive Shack Inc.
DS
| $131K | ﹤0.01% |
210,500
-102,800
| -33% | -$64K |
|
1224
Corvus Pharmaceuticals
CRVS
$440M
| $130K | ﹤0.01% |
159,300
| – | – |
|
1225
Gain Therapeutics
GANX
$62.9M
| $130K | ﹤0.01% |
40,000
| – | – |
|